RxDoctor Payments Data

Ashley August, PA

Surgical · Newark, DENPI 1770642183

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.4% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,623in general payments, 2019–2025

Across 131 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$460
  • Astellas Pharma US Inc$361
  • Exeltis, USA Inc.$203
  • AbbVie$187
  • Evofem Biosciences, Inc.$180
  • Sumitomo Pharma America, Inc.$152
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,52996%
  • Education$944%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,623 in reported general payments places this provider in the 90th percentile of 51 surgical providers in Delaware.

See all surgical providers in Delaware

Medicare billing

Part B allowed, 2024
$5,336
Medicare patients
122
Services billed
221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol28$2,495
Clobetasol Propionate19$723
ValacyclovirValacyclovir Hcl16$499
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$193

Paid to pharmacies, not to this prescriber.

Other surgical in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →